Drug major Sun Pharma, an Indian multinational pharmaceutical company headquartered in Mumbai, on July 13 announced a slew of changes & reshuffles in the senior management level in its Indian and North American operations.

Abhay Gandhi will takeover the role of the CEO of Sun Pharmas North American business from August 2016

Key Changes

According to the latest announcement, Abhay Gandhi is the CEO of Sun Pharmas North American business. On the other hand, Kal Sundaram, CEO of North America business & Taro Pharmaceutical Industries Ltd (Taro), will move to India as CEO (India and emerging markets).

Taro CEO Kal Sundaramall set to assumethe the position of CEO, India and emerging markets

Key Details

• Effective August 2016, Abhay Gandhi, CEO of India and sub-continent business, will take over as CEO, North America business, Sun Pharma.
• Effective January 2017, Kal Sundaram, currently CEO, North America business & Taro Pharmaceutical Industries Ltd (Taro, will assume the position of CEO, India and emerging markets.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.